<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
   <channel>
      <title>ana.press</title>
      <link>https://ana.ir</link>
      <description>ana.press</description>
      <managingEditor>info@ana.ir</managingEditor>
      <webMaster>info@iransamaneh.com</webMaster>
      <lastBuildDate>Mon, 21 Sep 2026 11:25:00 +0330</lastBuildDate>
      <generator>SepehrFeed V1.2</generator>
      <item>
         <title>WhartoCell demonstrates translational potential of umbilical cord-derived stem cells</title>
         <link>https://ana.ir/en/news/11216/whartocell-demonstrates-translational-potential-of-umbilical-cord-derived-stem-cells</link>
         <description>(Tehran Ana)- Developed by Royan Institute, WhartoCell is an allogeneic, off-the-shelf cell-based therapeutic product derived from umbilical cord mesenchymal stem cells, with development spanning basic research, preclinical and clinical studies, manufacturing and regulatory processes.</description>
         <author>info@ana.ir</author>
         <pubDate>17 Sep 2026 13:27:49 +0330</pubDate>
      </item>
   </channel>
</rss>